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Abstract
Background: Multiple congenital ocular anomalies (MCOA) syndrome is a hereditary congenital eye defect that
was first described in Silver colored Rocky Mountain horses. The mutation causing this disease is located within a
defined chromosomal interval, which also contains the gene and mutation that is associated with the Silver coat
color (PMEL17, exon 11). Horses that are homozygous for the disease-causing allele have multiple defects
(MCOA-phenotype), whilst the heterozygous horses predominantly have cysts of the iris, ciliary body or retina
(Cyst-phenotype). It has been argued that these ocular defects are caused by a recent mutation that is restricted to
horses that are related to the Rocky Mountain Horse breed. For that reason we have examined another horse
breed, the Icelandic horse, which is historically quite divergent from Rocky Mountain horses.
Results: We examined 24 Icelandic horses and established that the MCOA syndrome is present in this breed. Four
of these horses were categorised as having the MCOA-phenotype and were genotyped as being homozygous for
the PMEL17 mutation. The most common clinical signs included megaloglobus, iris stromal hypoplasia, abnormal
pectinate ligaments, iridociliary cysts occasionally extending into the peripheral retina and cataracts. The cysts and
pectinate ligament abnormalities were observed in the temporal quadrant of the eyes. Fourteen horses were
heterozygous for the PMEL17 mutation and were characterized as having the Cyst-phenotype with cysts and
occasionally curvilinear streaks in the peripheral retina. Three additional horses were genotyped as PMEL17
heterozygotes, but in these horses we were unable to detect cysts or other forms of anomalies.
One eye of a severely vision-impaired 18 month-old stallion, homozygous for the PMEL17 mutation was examined
by light microscopy. Redundant duplication of non-pigmented ciliary body epithelium, sometimes forming cysts
bulging into the posterior chamber and localized areas of atrophy in the peripheral retina were seen.
Conclusions: The MCOA syndrome is segregating with the PMEL17 mutation in the Icelandic Horse population.
This needs to be taken into consideration in breeding decisions and highlights the fact that MCOA syndrome is
present in a breed that are more ancient and not closely related to the Rocky Mountain Horse breed.
Background
Multiple congenital ocular anomalies (MCOA) syn-
drome is a hereditary condition consisting of a wide
range of ocular defects. It was first described in the
Rocky Mountain Horse breed [1]. Most affected horses
have a coat color called Silver (Figure 1). This color is
associated with a missense mutation in PMEL17 and has
a dominant mode of inheritance [2]. The mutation
causes a dilution of eumelanin (black and brown pig-
ment), most noticeable in mane and tail, into gray or
white. The body of the horse becomes slightly diluted in
color and often displays a dappled pattern. The PMEL17
mutation does not have an obvious effect on phenome-
lanin (red and yellow pigment), making it virtually
impossible to detect it phenotypically in horses lacking
dark pigment, for example chestnuts, white grays, palo-
minos, pearl- and champagne-colored horses. These
horses must be genotyped in order to determine if they
are carriers of the mutation. The PMEL17, exon 11,
mutation has been detected in an ancient sample recov-
ered from South Siberia. Radiocarbon dating of this
sample revealed that the Silver phenotype was present
as early as 800 years BC [3]. It is still unclear if the
MCOA locus and Silver locus are two separate but
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closely linked loci, or if only one mutation is present
with pleiotropic effects, influencing both coat color dilu-
tion and ocular development [4].
Horses with the MCOA syndrome can be categorized
into two separate groups depending on the severity of
disease [5]. Horses that are heterozygous for the dis-
ease-causing allele have less severe ocular anomalies,
mainly displaying peripheral cysts of the iris, cillary
body or retina (Cyst-phenotype). Horses that are homo-
zygous for the mutation have multiple anomalies,
including fluid-filled cysts of the iris, ciliary body or
retina, retinal dysplasia, megaloglobus, miotic pupils, iris
stromal hypoplasia and cataract (MCOA-phenotype)
[1,6]. Hence, the mutation displays a dose effect, were
double mutants have more serious defects than horses
carrying only one copy of the disease-causing allele [7].
Extensive breeding of horses with the desirable Silver
coat color has lead to a high frequency of MCOA syn-
drome in Rocky Mountain horses. It has been argued
that the ocular defects are caused by a recent mutation
that is restricted to horses that are related to the Rocky
Mountain Horse breed. Isolated findings of MCOA
syndrome have been reported in the related Kentucky
Mountain Saddle Horse, Mountain Pleasure Horse and
Morgan Horse breeds [1,8]. Two MCOA cases have also
been reported in the American Shetland pony [9], how-
ever this breed was developed by crossing imported
Shetland ponies to finer-built domestic breeds [10].
In this study, we describe identical lesions in Icelandic
horses, a breed developed in relative isolation on Iceland
during the last 1000 years [11].
Results
We have examined 24 Icelandic horses and established
that the MCOA syndrome is present in this breed. Four
of the horses were categorized as having the MCOA-
phenotype, which is the most severe form of the MCOA
syndrome. This was in agreement with their genotype as
they were homozygous for the exon 11, PMEL17 muta-
tion (Figure 1). An abnormal corneal contour, megalo-
globus was observed bilaterally in two horses with the
MCOA-phenotype. Iridal stromal hypoplasia was found
in all four horses. Miotic pupils that were irresponsive
to light stimuli and repeated administration of tropica-
mide were seen in two horses, whereas the other two
horses in this group had slightly miotic pupils that con-
stricted when light was shone into the eye and instilla-
tion of tropicamide caused some, but not normal
dilation of the pupils (Figure 2a). A widened, densely
white perilimbal zone indicating iridocorneal angle
anomalies was evident in the temporal quadrant in two
of these horses (Figure 2b). Nuclear cataracts extending
into the epinuclear and cortical areas were present in
three homozygote MCOA horses examined, but not in a
12 month-old mare. All four horses with the MCOA-
phenotype had multiple translucent, fluid-filled iridocili-
ary cysts in the temporal quadrant of the eye. Involve-
ment of the peripheral retina, always in the temporal
Figure 1 An Icelandic horse with the Silver coat colour. This
horse is genetically black but the hairs have been lightened as a
result of the PMEL17 mutation. This horse is homozygous for the
mutation and displayed the MCOA-phenotype. Note that the pupil
is poorly dilated even though a mydriatic has been applied
repeatedly one hour before the photo was taken.
Figure 2 Iridal abnormalities and cataracts in the MCOA-
phenotype. A) Iris stromal hypoplasia with miotic pupils with poor
or no response to tropicamide was seen in all horses with the
MCOA-phenotype. Cortical and nuclear cataractous changes in the
lens contributed to the visual impairment. The horse in figure B)
shows a regional abnormality of the pectinate ligament heralded by
a widened, white perilimbal zone temporally (red arrows).
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quadrant, was seen as ophthalmoscopically visible cysts
extending over the ora serrata or demarcation lines and
focal retinal atrophy where the neuroretina previously
had been detached (Figure 3).
Light-microscopic examination of one globe showed
redundant duplication of non-pigmented ciliary body
epithelium, sometimes forming cysts bulging into the
posterior chamber. In the peripheral retina localized
areas of retinal atrophy and loss of photoreceptors were
seen.
Fourteen horses were classified with the Cyst-pheno-
type, and were shown to be heterozygous for the
PMEL17 mutation. All of these horses showed translu-
cent, fluid filled cysts, ranging from single small cysts in
both eyes of one individual, to large lobulated cysts
(Figure 4) with or without curvilinear streaks extending
into the temporal retina. All horses with the Cyst-phe-
notype showed normal pupillary light reflexes, dazzle
reflexes and menace responses and normal dilation of
the pupil after tropicamide application, contrary to the
MCOA-phenotype horses.
Three additional horses displayed the Silver pheno-
type, were heterozygous for the PMEL17 mutation, but
did not display any detectable clinical signs of the Cyst-
phenotype. Three non-Silver Icelandic horses were
examined as controls. None of these displayed the Cyst-
or the MCOA-phenotype.
Numerous pigmented folds indicating multifocal ret-
inal dysplasia in the dorsal tapetal fundus were fre-
quently observed in horses with the Cyst- or the
MCOA-phenotype.
Discussion
In this study we have shown that the MCOA syndrome
is segregating with the PMEL17 mutation in the Icelan-
dic Horse population. This makes the hypothesis that
the MCOA mutation has recently arisen unlikely.
Icelandic horses are believed to be descendant from
horses brought to Iceland by the Vikings around 900
AD. They were possibly interbred later with ponies
brought over from Ireland/ United Kingdom, which
were the ancestors of the Shetland, Highland, and Con-
nemara ponies. The Icelandic parliament banned import
of horses into Iceland in 982 AD, and consequently the
breed has been isolated for more than 1000 years.
It is probably not a coincidence that MCOA syndrome
was first found in the Rocky Mountain Horse breed. Stal-
lions and mares of this breed expressing the Silver phe-
notype have been used extensively in breeding. As the
frequency of the Silver allele increased in the population,
so did the frequency of the double mutants (homozy-
gotes). In homozygous individuals, the ocular defects
become the most obvious. This is reflected both in a phe-
notypic characteristic with bulging eyes (megaloglobus)
and in an increased number of horses with impaired
vision. In other breeds of horses where the mutation is
not as common, carriers are most likely to be heterozy-
gous [12]. This poses a particular problem to breeders as
ocular anomalies in heterozygotes are usually only
detected after careful examination by a trained ophthal-
mologist. Therefore, breeding societies may be unaware
of the prevalence of the disease in their Silver horses,
which warrants further clinical investigations.
Figure 3 Cystic lesions extending into the retina. A) Cysts
involving the peripheral retina in the temporal quadrant or
curvilinear demarcation lines and focal areas of retinal atrophy were
occasionally seen in both PMEL17 mutation heterozygotes and
homozygotes. B) Post-mortem specimen showing multiple
demarcation lines (black arrows) extending towards the optic nerve
head and an area where the retina is still detached (white arrow).
Figure 4 Multiple iridociliary cysts in an Icelandic horse with
the exon 11, PMEL17 mutation. Multiple iridociliary cysts in the
temporal quadrant were seen in all homozygotes and most
heterozygotes. The size of the cysts ranged from a few millimetres
in diameter to well over a centimetre.
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We could not detect any clinical signs of MCOA syn-
drome in three PMEL17 heterozygous horses. This has
also been reported in previous studies [4,5]. To date, we
do not know if this was caused by limitations in our
detection method or if it was due to non- penetrance of
the mutation. However, horses without detectable cysts,
that carry the PMEL17 mutation, still produce affected
offspring [5].
Horses with the MCOA-phenotype are at particular
risk of having impaired vision, and difficulties in adapt-
ing to changing light conditions are probably a common
phenomenon in these horses. Some individuals have
more severe impairment of their vision, causing abnor-
mal behavior and an inability to perform. MCOA and
PMEL17 are tightly linked, so breeding PMEL17 muta-
tion carriers only to known non-carriers would practi-
cally eliminate the risk of producing horses with vision
threatening abnormalities caused by this syndrome.
Conclusion
MCOA syndrome is segregating with the PMEL17
mutation in the Icelandic Horse population. This should
be taken in to consideration for breeding decisions and
highlights the fact that the MCOA syndrome is present
in a breed that is not closely related to the Rocky
Mountain breed of horses.
Methods
We have examined a total of 24 Icelandic horses. Horses
were certified by the Swedish breed registry and
included 19 females and 5 males (Table 1). Twenty-one
horses had a Silver coat colour and three were non-Sil-
ver. The Silver colour could be traced back to five dif-
ferent stallions. The age of horses ranged from 1-23
years old (median: 5 years).
Blood samples were collected at the time of clinical
examination and DNA was extracted using a GeneMole
robot (Mole Genetics, Lysaker, Norway). All horses were
genotyped for the mutation in PMEL17, exon 11, that is
associated with the Silver coat color with pyrosequen-
cing as described in Brunberg et al [2].
One 18 month-old stallion with the MCOA-phenotype
and severe visual impairment was euthanized according
the owners request. The left eye was enucleated,
hemisectioned and fixed in 4% glutaraldehyde. The
globe was then submitted for light-microscopic
examination.
Pupillary light reflexes, dazzle reflexes and menace
responses were examined in all horses. The anterior and
posterior segments of the eyes were examined by slit-
lamp biomicroscopy (Kowa SL-14, Kowa Co. Ltd.,
Tokyo, Japan) and indirect ophthalmoscopy (Heine 500,
Heine Optotechnik, Herrsching, Germany) before and
after induction of mydriasis with tropicamide eye drops
(Mydriacyl 0.5%, Alcon Sverige AB, Stockholm, Sweden).
The examinations were approved by the Ethics Commit-
tee for Animal Experiments in Uppsala, Sweden and
informed consent was received from all horse owners.
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